Cvs Health CORP 8-K filings
NYSE
CVS Health Corporation has successfully issued $5 billion in senior notes across five tranches with varying maturities and interest rates.
NYSE
CVS Health Corporation has entered into an underwriting agreement to issue and sell $5 billion in aggregate principal amount of senior notes with varying maturities.
NYSE
CVS Health lowered its full-year 2024 earnings and cash flow guidance due to higher than expected medical costs, particularly in its Medicare Advantage business, despite a revenue increase in the first quarter.
NYSE
CVS Health's senior management reaffirmed their full-year 2024 financial guidance during an investor meeting and webcast on March 5, 2024.
NYSE
CVS Health announced a revenue increase for both the fourth quarter and full year of 2023, alongside a revised 2024 earnings and cash flow guidance.